COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
EPA:CRI - Euronext Paris - Matif - FR0000130692 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to CRI. CRI was compared to 14 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of CRI have multiple concerns. CRI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
CRI had positive earnings in the past year.
CRI had a positive operating cash flow in the past year.
Of the past 5 years CRI 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CRI reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of 0.72%, CRI is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
CRI has a worse Return On Equity (2.33%) than 78.57% of its industry peers.
CRI has a worse Return On Invested Capital (5.11%) than 64.29% of its industry peers.
CRI had an Average Return On Invested Capital over the past 3 years of 4.65%. This is in line with the industry average of 6.20%.
The last Return On Invested Capital (5.11%) for CRI is above the 3 year average (4.65%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROIC | 5.11% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
CRI has a worse Profit Margin (1.00%) than 85.71% of its industry peers.
CRI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.54%, CRI is doing worse than 71.43% of the companies in the same industry.
CRI's Operating Margin has been stable in the last couple of years.
CRI has a worse Gross Margin (28.34%) than 85.71% of its industry peers.
In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRI is destroying value.
Compared to 1 year ago, CRI has more shares outstanding
The number of shares outstanding for CRI has been increased compared to 5 years ago.
Compared to 1 year ago, CRI has an improved debt to assets ratio.
2.2 Solvency
CRI has an Altman-Z score of 1.51. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
CRI has a worse Altman-Z score (1.51) than 71.43% of its industry peers.
CRI has a debt to FCF ratio of 14.78. This is a negative value and a sign of low solvency as CRI would need 14.78 years to pay back of all of its debts.
CRI's Debt to FCF ratio of 14.78 is in line compared to the rest of the industry. CRI outperforms 42.86% of its industry peers.
CRI has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
CRI has a Debt to Equity ratio of 1.05. This is in the lower half of the industry: CRI underperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Altman-Z | 1.51 |
ROIC/WACC0.75
WACC6.83%
2.3 Liquidity
CRI has a Current Ratio of 1.25. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
CRI's Current ratio of 1.25 is on the low side compared to the rest of the industry. CRI is outperformed by 78.57% of its industry peers.
A Quick Ratio of 0.82 indicates that CRI may have some problems paying its short term obligations.
CRI has a worse Quick ratio (0.82) than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1749.48%, which is quite impressive.
CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.59% yearly.
Looking at the last year, CRI shows a quite strong growth in Revenue. The Revenue has grown by 11.85% in the last year.
CRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.10% yearly.
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
3.2 Future
Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 29.06% on average per year.
The Revenue is expected to grow by 5.77% on average over the next years.
EPS Next Y146.66%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPS Next 5YN/A
Revenue Next Year10.86%
Revenue Next 2Y8.9%
Revenue Next 3Y5.77%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 36.56 indicates a quite expensive valuation of CRI.
71.43% of the companies in the same industry are cheaper than CRI, based on the Price/Earnings ratio.
CRI is valuated expensively when we compare the Price/Earnings ratio to 24.12, which is the current average of the S&P500 Index.
CRI is valuated reasonably with a Price/Forward Earnings ratio of 10.74.
Based on the Price/Forward Earnings ratio, CRI is valued a bit cheaper than 78.57% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CRI to the average of the S&P500 Index (20.42), we can say CRI is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.56 | ||
| Fwd PE | 10.74 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRI is valued a bit cheaper than the industry average as 64.29% of the companies are valued more expensively.
CRI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CRI is cheaper than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.13 | ||
| EV/EBITDA | 7.6 |
4.3 Compensation for Growth
CRI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRI's earnings are expected to grow with 29.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y74.67%
EPS Next 3Y29.06%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.13%, CRI has a reasonable but not impressive dividend return.
CRI's Dividend Yield is slightly below the industry average, which is at 3.93.
With a Dividend Yield of 1.13, CRI pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPA:CRI (5/8/2025, 7:00:00 PM)
11.7
-0.06 (-0.51%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners10.24%
Inst Owner ChangeN/A
Ins Owners64.27%
Ins Owner ChangeN/A
Market Cap290.86M
Analysts75.56
Price Target14.24 (21.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.56 | ||
| Fwd PE | 10.74 | ||
| P/S | 0.4 | ||
| P/FCF | 10.13 | ||
| P/OCF | 6.54 | ||
| P/B | 0.93 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.6 |
EPS(TTM)0.32
EY2.74%
EPS(NY)1.09
Fwd EY9.31%
FCF(TTM)1.15
FCFY9.87%
OCF(TTM)1.79
OCFY15.3%
SpS29.35
BVpS12.61
TBVpS-0.27
PEG (NY)0.25
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.72% | ||
| ROE | 2.33% | ||
| ROCE | 6.99% | ||
| ROIC | 5.11% | ||
| ROICexc | 6.21% | ||
| ROICexgc | 14.36% | ||
| OM | 6.54% | ||
| PM (TTM) | 1% | ||
| GM | 28.34% | ||
| FCFM | 3.93% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexcg growth 3Y-6.3%
ROICexcg growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 14.78 | ||
| Debt/EBITDA | 4.24 | ||
| Cap/Depr | 52.67% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.27% | ||
| Profit Quality | 393.15% | ||
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 1.51 |
F-Score7
WACC6.83%
ROIC/WACC0.75
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1749.48%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%518.18%
EPS Next Y146.66%
EPS Next 2Y74.67%
EPS Next 3Y29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%15.47%
Revenue Next Year10.86%
Revenue Next 2Y8.9%
Revenue Next 3Y5.77%
Revenue Next 5YN/A
EBIT growth 1Y84.88%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year149.63%
EBIT Next 3Y40.25%
EBIT Next 5YN/A
FCF growth 1Y152.76%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y253.45%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%